Nasopharyngeal Diseases  >>  TheraCIM (nimotuzumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
NCT01616849: Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

Completed
2
39
RoW
cisplatin and 5-Fu combined with nimotuzumab
Sun Yat-sen University, Fujian Cancer Hospital, First People's Hospital of Foshan, People's Hospital of Guangxi, Guangxi Medical University, Guangzhou Medical University, Hubei Cancer Hospital, Hunan Provincial Cancer Hospital, Hangzhou Cancer Hospital, Wuhan Union Hospital, China, Tongji Hospital, Jiangxi Provincial Cancer Hospital, Affiliated Cancer Hospital of Shantou University Medical College, Wuhan University, Zhejiang Cancer Hospital
Stage IV Nasopharyngeal Carcinoma
07/15
07/15

Download Options